• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部进展期食管胃交界腺癌的当前管理

Current Management of Locally Advanced Junction Esophagogastric Adenocarcinoma.

作者信息

Birla Rodica, Hoara Petre, Caragui Andrei, Cristian Marica, Constantinoiu Silviu

出版信息

Chirurgia (Bucur). 2018 Jan-Feb;113(1):38-45. doi: 10.21614/chirurgia.113.1.38.

DOI:10.21614/chirurgia.113.1.38
PMID:29509530
Abstract

Adenocarcinoma of the gastroesophageal junction is more common in the West. Preoperative chemotherapy or chemoradiotherapy is performed for locally advanced disease. Recent studies are suggesting higher rates of curative resection and reduced rates of local recurrence in patients with neoadjuvant combination of chemotherapy and radiation therapy. The role of targeted agents in neoadjuvant therapy is under investigation.

摘要

胃食管交界腺癌在西方更为常见。对于局部晚期疾病,会进行术前化疗或放化疗。最近的研究表明,新辅助化疗与放疗联合治疗的患者,其根治性切除率更高,局部复发率更低。靶向药物在新辅助治疗中的作用正在研究中。

相似文献

1
Current Management of Locally Advanced Junction Esophagogastric Adenocarcinoma.局部进展期食管胃交界腺癌的当前管理
Chirurgia (Bucur). 2018 Jan-Feb;113(1):38-45. doi: 10.21614/chirurgia.113.1.38.
2
Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial.术前化疗与放化疗治疗食管胃交界部局部晚期腺癌(POET):一项对照随机试验的长期结果。
Eur J Cancer. 2017 Aug;81:183-190. doi: 10.1016/j.ejca.2017.04.027.
3
Controversies in the treatment of local and locally advanced gastric and esophageal cancers.局部和局部进展期胃和食管癌症治疗的争议。
J Clin Oncol. 2015 Jun 1;33(16):1754-9. doi: 10.1200/JCO.2014.59.7765. Epub 2015 Apr 27.
4
A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma.一项新辅助多西他赛、奥沙利铂和 S-1(DOS)化疗,随后手术和辅助 S-1 化疗治疗潜在可切除胃或胃食管结合部腺癌的 II 期研究。
Cancer Chemother Pharmacol. 2013 Oct;72(4):815-23. doi: 10.1007/s00280-013-2257-z. Epub 2013 Aug 7.
5
Chemotherapy for Esophageal Adenocarcinoma.食管腺癌的化疗
Methods Mol Biol. 2018;1756:19-34. doi: 10.1007/978-1-4939-7734-5_3.
6
Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis.新辅助放化疗对比新辅助化疗可改善局部进展期胃食管结合部腺癌患者的生存:一项倾向评分匹配分析。
BMC Surg. 2021 Mar 17;21(1):137. doi: 10.1186/s12893-021-01136-z.
7
(Neo)-adjuvant chemo(-radio) therapy for adenocarcinomas of the gastroesophageal junction and the stomach in the West.(新)辅助化疗(放)疗用于治疗西方的胃食管结合部和胃腺癌。
Dig Surg. 2013;30(2):112-8. doi: 10.1159/000350935. Epub 2013 Jul 18.
8
Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG).辅助 SOX 化疗与 D2 根治性切除局部晚期食管胃结合部(EGJ)腺癌后的同期放化疗比较:一项随机 III 期试验(ARTEG)的研究方案。
Trials. 2021 Oct 30;22(1):753. doi: 10.1186/s13063-021-05617-7.
9
Esophagogastric junction and gastric adenocarcinoma: neoadjuvant and adjuvant therapy, and future directions.食管胃结合部和胃腺癌:新辅助和辅助治疗及未来方向。
Oncology (Williston Park). 2014 Jun;28(6):505-12.
10
Combined taxane-based chemotherapy and intensity-modulated radiotherapy with simultaneous integrated boost for gastroesophageal junction adenocarcinoma.联合紫杉烷类化疗和强度调制放疗并同步推量治疗胃食管结合部腺癌。
Future Oncol. 2018 Mar;14(6s):47-51. doi: 10.2217/fon-2017-0342.

引用本文的文献

1
Short-term postoperative complications and prognostic factors in patients with adenocarcinoma of the esophagogastric junction.胃食管结合部腺癌患者的短期术后并发症和预后因素。
Thorac Cancer. 2018 Aug;9(8):1018-1025. doi: 10.1111/1759-7714.12780. Epub 2018 Jun 21.